Results 161 to 170 of about 373,575 (318)

George Fox College Life, February 1989

, 1987
Alumni newspaper of George Fox College.https://digitalcommons.georgefox.edu/gfc_life/1100/thumbnail ...
George Fox University Archives
core  

Normal‐Appearing White Matter Injury Mediates Chronic Deep Venous Hypoxia and Disease Progression in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore how cerebral hypoxia and Normal‐Appearing White Matter (NAWM) integrity affect MS lesion burden and clinical course. Methods Seventy‐nine MS patients, including 13 clinically isolated syndrome (CIS) patients and 66 relapsing–remitting multiple sclerosis (RRMS) patients, and 44 healthy controls (HCs) were recruited from ...
Xinli Wang, Huiying Wang, Zhizheng Zhuo, Ai Guo, Ke Lv, Decai Tian, Chao Chai, Yunyun Duan, Shuang Xia   +8 more
wiley   +1 more source

Spatially explicit power analysis reveals challenges for a long-term threatened species monitoring program in Australia. [PDF]

Ecol Appl
Menon V, Southwell D, Robley A, Rees MW, Wilkinson DP, Giljohann K, Pascoe J, Wintle B, Hradsky BA.   +8 more
europepmc   +1 more source

George Fox Frosh Beanie

Blue and Gold freshman beanie with George Fox Frosh in blue on Gold. Appears to be felt. Has some tears.
George Fox University Archives
core  

George Fox College Life, June 1990

, 1990
Alumni newspaper of George Fox College.https://digitalcommons.georgefox.edu/gfc_life/1108/thumbnail ...
George Fox University Archives
core  

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane, Giorgia Coratti, Chiara Cutrì, Antonio Varone, Riccardo Masson, Adele D'Amico, Valeria Sansone, Sonia Messina, Federica Ricci, Chiara Ticci, Claudio Bruno, Caterina Agosto, Francesca Benedetti, Antonella Pini, Sabrina Siliquini, Massimiliano Filosto, Alberto Zambon, Ilaria Bitetti, Maria Rosaria Manna, Claudia Dosi, Riccardo Zanin, Stefano Parravicini, Roberto De Sanctis, Giulia Stanca, Michela Catteruccia, Michele Tosi, Irene Mizzoni, Emilio Albamonte, Valentina Franchino, Maria Sframeli, Ilaria Cavallina, Elena Procopio, Michele Sacchini, Simone Morando, Noemi Brolatti, Federica Trucco, Gaia Scarpini, Elena Briganti, Beatrice Berti, Concetta Palermo, Daniela Leone, Stefano C. Previtali, Eugenio Mercuri, the ITASMAC working group   +43 more
wiley   +1 more source

Correction: Working to Increase Stability through Exercise (WISE): screening, recruitment, and baseline characteristics. [PDF]

Trials
Sciamanna CN, Ballentine NH, Bopp M, Chinchilli VM, Ciccolo JT, Delauter G, Fisher A, Fox EJ, De Beur SMJ, Kearcher K, Kraschnewski JL, Lehman E, McTigue KM, McAuley E, Paranjape A, Rodriguez-Colon S, Rovniak LS, Rutt K, Smyth JM, Stewart KJ, Stuckey HL, Tsay A.   +21 more
europepmc   +1 more source

George Fox College Life, March 1993

, 1993
Alumni newspaper of George Fox College.https://digitalcommons.georgefox.edu/gfc_life/1120/thumbnail ...
George Fox University Archives
core  

Quantifying the Impact of Ocrelizumab on Paramagnetic Rim Lesions in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Paramagnetic rim lesions (PRLs) are a subset of chronic active multiple sclerosis (MS) lesions marked by iron‐laden microglia and macrophages. Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, suppresses acute MS activity, but its effect on PRLs remains unclear. In a longitudinal study of 29 ocrelizumab‐treated patients with at least
Kimberly H. Markowitz, Neha V. Safi, Iliana Pliska‐Bloch, Ulrike W. Kaunzner, Ha Luu, Mert Sisman, Yi Wang, Thanh D. Nguyen, Sandra Hurtado Rúa, Susan A. Gauthier   +9 more
wiley   +1 more source

Dry Mouth by Report or by Measure? Comparison of Fox and Xerostomia Inventory Scores with Sialometry. [PDF]

BMC Oral Health
Ostrowska M, Settaf-Cherif L, Kiersztyn J, Ostrowski A, Drewa TA, Adamowicz J, Wróbel MJ.   +6 more
europepmc   +1 more source